Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder.

Saxena S, Gorbis E, O'Neill J, Baker SK, Mandelkern MA, Maidment KM, Chang S, Salamon N, Brody AL, Schwartz JM, London ED.

Mol Psychiatry. 2009 Feb;14(2):197-205. doi: 10.1038/sj.mp.4002134. Epub 2008 Jan 8.

2.

Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder.

O'Neill J, Gorbis E, Feusner JD, Yip JC, Chang S, Maidment KM, Levitt JG, Salamon N, Ringman JM, Saxena S.

J Psychiatr Res. 2013 Apr;47(4):494-504. doi: 10.1016/j.jpsychires.2012.11.010. Epub 2013 Jan 4.

3.

Regional homogeneity of spontaneous brain activity in adult patients with obsessive-compulsive disorder before and after cognitive behavioural therapy.

Yang XY, Sun J, Luo J, Zhong ZX, Li P, Yao SM, Xiong HF, Huang FF, Li ZJ.

J Affect Disord. 2015 Dec 1;188:243-51. doi: 10.1016/j.jad.2015.07.048. Epub 2015 Aug 28.

PMID:
26378734
4.

Cerebral glucose metabolism in obsessive-compulsive hoarding.

Saxena S, Brody AL, Maidment KM, Smith EC, Zohrabi N, Katz E, Baker SK, Baxter LR Jr.

Am J Psychiatry. 2004 Jun;161(6):1038-48.

PMID:
15169692
5.

Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET.

Apostolova I, Block S, Buchert R, Osen B, Conradi M, Tabrizian S, Gensichen S, Schröder-Hartwig K, Fricke S, Rufer M, Weiss A, Hand I, Clausen M, Obrocki J.

Psychiatry Res. 2010 Nov 30;184(2):105-16. doi: 10.1016/j.pscychresns.2010.08.012. Epub 2010 Oct 14.

PMID:
20947317
6.

Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression.

Saxena S, Brody AL, Ho ML, Zohrabi N, Maidment KM, Baxter LR Jr.

Am J Psychiatry. 2003 Mar;160(3):522-32.

PMID:
12611834
7.

MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.

O'Neill J, Piacentini JC, Chang S, Levitt JG, Rozenman M, Bergman L, Salamon N, Alger JR, McCracken JT.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10;36(1):161-8. doi: 10.1016/j.pnpbp.2011.09.007. Epub 2011 Oct 1.

8.

Metabolic imaging of bilateral anterior capsulotomy in refractory obsessive compulsive disorder: an FDG PET study.

Zuo C, Ma Y, Sun B, Peng S, Zhang H, Eidelberg D, Guan Y.

J Cereb Blood Flow Metab. 2013 Jun;33(6):880-7. doi: 10.1038/jcbfm.2013.23. Epub 2013 Feb 27.

9.

Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.

Saxena S, Brody AL, Ho ML, Alborzian S, Maidment KM, Zohrabi N, Ho MK, Huang SC, Wu HM, Baxter LR Jr.

Arch Gen Psychiatry. 2002 Mar;59(3):250-61.

PMID:
11879163
10.

Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial.

Hoexter MQ, de Souza Duran FL, D'Alcante CC, Dougherty DD, Shavitt RG, Lopes AC, Diniz JB, Deckersbach T, Batistuzzo MC, Bressan RA, Miguel EC, Busatto GF.

Neuropsychopharmacology. 2012 Feb;37(3):734-45. doi: 10.1038/npp.2011.250. Epub 2011 Oct 26.

11.

Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive-compulsive disorder.

Hoexter MQ, Dougherty DD, Shavitt RG, D'Alcante CC, Duran FL, Lopes AC, Diniz JB, Batistuzzo MC, Evans KC, Bressan RA, Busatto GF, Miguel EC.

Eur Neuropsychopharmacol. 2013 Jul;23(7):569-80. doi: 10.1016/j.euroneuro.2012.06.014. Epub 2012 Jul 27.

PMID:
22841131
12.

[Definition of treatment-refractory obsessive-compulsive disorder based on cognitive behavioral therapy].

Shimizu E.

Seishin Shinkeigaku Zasshi. 2013;115(9):975-80. Review. Japanese.

PMID:
24228475
13.

Cognitive behavior therapy for comorbid obsessive-compulsive disorder in high-functioning autism spectrum disorders: a randomized controlled trial.

Russell AJ, Jassi A, Fullana MA, Mack H, Johnston K, Heyman I, Murphy DG, Mataix-Cols D.

Depress Anxiety. 2013 Aug;30(8):697-708. doi: 10.1002/da.22053. Epub 2013 Feb 6.

PMID:
23389964
14.

Cognitive-behavioural therapy augments the effects of deep brain stimulation in obsessive-compulsive disorder.

Mantione M, Nieman DH, Figee M, Denys D.

Psychol Med. 2014 Dec;44(16):3515-22. doi: 10.1017/S0033291714000956. Epub 2014 Apr 25.

PMID:
25065708
15.

Can memory and executive functions in patients with obsessive-compulsive disorder predict outcome of cognitive behavioural therapy?

Vandborg SK, Hartmann TB, Bennedsen BE, Pedersen AD, Thomsen PH.

Nord J Psychiatry. 2016;70(3):183-9. doi: 10.3109/08039488.2015.1074282. Epub 2015 Sep 2.

PMID:
26329120
16.

Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial.

Kennedy SH, Konarski JZ, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, Mayberg HS.

Am J Psychiatry. 2007 May;164(5):778-88.

PMID:
17475737
17.

Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder.

Schwartz JM, Stoessel PW, Baxter LR Jr, Martin KM, Phelps ME.

Arch Gen Psychiatry. 1996 Feb;53(2):109-13.

PMID:
8629886
18.

Developmental aspects of error and high-conflict-related brain activity in pediatric obsessive-compulsive disorder: a fMRI study with a Flanker task before and after CBT.

Huyser C, Veltman DJ, Wolters LH, de Haan E, Boer F.

J Child Psychol Psychiatry. 2011 Dec;52(12):1251-60. doi: 10.1111/j.1469-7610.2011.02439.x. Epub 2011 Jul 27.

PMID:
21793825
19.

Predicting response to cognitive behavioral therapy in contamination-based obsessive-compulsive disorder from functional magnetic resonance imaging.

Olatunji BO, Ferreira-Garcia R, Caseras X, Fullana MA, Wooderson S, Speckens A, Lawrence N, Giampietro V, Brammer MJ, Phillips ML, Fontenelle LF, Mataix-Cols D.

Psychol Med. 2014 Jul;44(10):2125-37. doi: 10.1017/S0033291713002766. Epub 2013 Nov 12.

PMID:
24229474
20.

Resting-state connectivity of the amygdala predicts response to cognitive behavioral therapy in obsessive compulsive disorder.

Göttlich M, Krämer UM, Kordon A, Hohagen F, Zurowski B.

Biol Psychol. 2015 Oct;111:100-9. doi: 10.1016/j.biopsycho.2015.09.004. Epub 2015 Sep 18.

PMID:
26388257

Supplemental Content

Support Center